← FDA Drug Approvals (Drugs@FDA)

NAFCILLIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2012-12-26

Drug application

FDA Application #

ANDA091613

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAFCILLIN SODIUM

Generic name

NAFCILLIN SODIUM

Active ingredients

NAFCILLIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

EUGIA PHARMA SPECLTS

Manufacturer

Eugia US LLC

First approval

2012-12-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown